Crop Life Science (NSE:CLSL) Marketable Securities: ₹24 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:CLSL Crop Life Science Ltd NSE:CLSL
56 GF Score
Price ₹60.95
GF Value ₹55.37
Valuation Fairly Valued
! 8 Warning Signs
View Full Analysis

What is Crop Life Science Marketable Securities?

Crop Life Science NSE:CLSL +0.91% 56 Marketable Securities is ₹24 Mil as of Mar. 2026. GuruFocus rates NSE:CLSL with a GF Score™ of 56/100 and a GF Value™ of ₹55.37 (Fairly Valued). The stock has 8 warning signs investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Crop Life Science's Marketable Securities for the quarter that ended in Mar. 2026 was ₹24 Mil.

Crop Life Science's annual Marketable Securities declined from Mar. 2024 (₹3 Mil) to Mar. 2025 (₹2 Mil) but then increased from Mar. 2025 (₹2 Mil) to Mar. 2026 (₹24 Mil).

Crop Life Science  (NSE:CLSL) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Crop Life Science Marketable Securities Related Terms

Crop Life Science Marketable Securities Historical Data

* Premium members only.

The historical data trend for Crop Life Science's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Crop Life Science Marketable Securities Chart

Crop Life Science Annual Data
Trend Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Marketable Securities
Get a 7-Day Free Trial 0.00 0.00 3.31 1.99 23.61

Crop Life Science Semi-Annual Data
Mar20 Mar21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 3.31 8.36 1.99 7.63 23.61
NSE:CLSL
56GF Score
Crop Life Science Ltd NSE:CLSL
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Crop Life Science Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of ₹24 Mil mean?
Crop Life Science (NSE:CLSL) has a Marketable Securities of ₹24 Mil as of Mar. 2026. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Crop Life Science and its competitors.
Is Crop Life Science's Marketable Securities too high?
Crop Life Science's current Marketable Securities is ₹24 Mil. Overall, Crop Life Science has a GF Score™ of 56/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Crop Life Science's Marketable Securities compare to CTVA and CF?
Crop Life Science's Marketable Securities of ₹24 Mil can be compared against companies in the Agriculture industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for an Agriculture company?
A good Marketable Securities depends on the Agriculture industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Crop Life Science and its competitors. Crop Life Science's current Marketable Securities is ₹24 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Crop Life Science stock overvalued right now?
Based on GuruFocus' analysis, Crop Life Science (NSE:CLSL) is currently considered Fairly Valued. The stock's GF Value™ is ₹55.37, compared to a current price of ₹60.95 — trading 10.1% above its estimated fair value. The current Marketable Securities is ₹24 Mil. Crop Life Science's overall GF Score™ is 56/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Crop Life Science (NSE:CLSL), the current Marketable Securities is ₹24 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Crop Life Science (NSE:CLSL) Overvalued in 2026?

Based on GuruFocus' analysis, Crop Life Science stock appears to be overvalued. The current stock price of ₹60.95 is trading 10.1% above its estimated GF Value™ of ₹55.37. GuruFocus considers Crop Life Science to be Fairly Valued.

Key valuation signals for NSE:CLSL:

  • Marketable Securities: ₹24 Mil
  • GF Value™: ₹55.37 vs. price of ₹60.95 (10.1% above fair value)
  • GF Score™: 56/100 with 8 warning signs

No single metric tells the full story. See the NSE:CLSL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Crop Life Science Business Description

Address Old Padra Road, 6th Floor, ABS Tower, Near Chakli Circle, Vadodara, GJ, IND, 390007
Crop Life Science Ltd manufactures and distributes a broad range of crop protection chemicals, including pesticides, insecticides, fungicides, herbicides, micro fertilizers, bio-pesticides, bio-fertilizers, plant growth regulators, and soil plant health products. The company operates its manufacturing facility in Ankleshwar, Gujarat, leveraging technology to maintain quality standards. It serves agricultural markets within India and exports to countries including Indonesia, Bangladesh, Egypt, Myanmar, Vietnam, and Sudan. Segments include Agro chemicals and Agro trade. Revenue is generated through the sale of its agricultural chemicals and related products to farmers, distributors, and agri-businesses.
56GF Score

Get the complete analysis for NSE:CLSL

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹60.95
Price
₹55.37
GF Value